Literature DB >> 19765941

Cannabinoid hyperemesis: a case series.

Michael W Donnino1, Michael N Cocchi, Joseph Miller, Jonathan Fisher.   

Abstract

BACKGROUND: Cannabinoid use is prevalent in the United States, with recent reports of increased usage among younger Americans. Traditionally, cannabinoids have been used recreationally or as antiemetics; however, recent reports suggest that chronic abuse can result in the paradoxical effect of a cyclic vomiting syndrome, termed cannabinoid hyperemesis.
OBJECTIVE: We report on this recently described clinical syndrome characterized by severe nausea and hyperemesis in the setting of chronic cannabinoid use. CASE REPORTS: We report the cases of 3 patients who presented to two academic emergency departments (EDs) on multiple occasions with nausea and vomiting in the setting of chronic cannabinoid use. There were extensive medical evaluations and frequent inpatient hospital admissions before the diagnosis of cannabinoid hyperemesis was considered.
CONCLUSION: With the relatively high prevalence of cannabinoid use in the United States and increasing interest in the applications of marijuana for therapeutic purposes, this entity may be encountered in the ED. Cannabinoid hyperemesis should be considered in the differential diagnosis of patients presenting with similar symptoms.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765941     DOI: 10.1016/j.jemermed.2009.07.033

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  16 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Cyclic vomiting presentations following marijuana liberalization in Colorado.

Authors:  Howard S Kim; John D Anderson; Omeed Saghafi; Kennon J Heard; Andrew A Monte
Journal:  Acad Emerg Med       Date:  2015-04-22       Impact factor: 3.451

3.  Case of cannabinoid hyperemesis syndrome with long-term follow-up.

Authors:  Jae Myung Cha; Richard A Kozarek; Otto S Lin
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 4.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

Review 5.  Cannabinoid hyperemesis syndrome: a guide for the practising clinician.

Authors:  Sanjin Bajgoric; Kiran Samra; Subashini Chandrapalan; Nishant Gautam
Journal:  BMJ Case Rep       Date:  2015-12-23

Review 6.  Cannabinoid hyperemesis syndrome.

Authors:  Jonathan A Galli; Ronald Andari Sawaya; Frank K Friedenberg
Journal:  Curr Drug Abuse Rev       Date:  2011-12

7.  Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.

Authors:  Andrea Bollom; Jasmine Austrie; William Hirsch; Judy Nee; Daniel Friedlander; Johanna Iturrino; Sarah Ballou; Anthony Lembo
Journal:  J Clin Gastroenterol       Date:  2018-10       Impact factor: 3.062

8.  The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.

Authors:  Michelle Carbuto; R Andrew Sewell; Ashley Williams; Kim Forselius-Bielen; Gabriel Braley; Jacqueline Elander; Brian Pittman; Ashley Schnakenberg; Savita Bhakta; Edward Perry; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2011-08-16       Impact factor: 4.530

9.  Cannabinoid hyperemesis syndrome.

Authors:  Shusen Sun; Anthony E Zimmermann
Journal:  Hosp Pharm       Date:  2013-09

10.  Cannabinoid hyperemesis syndrome.

Authors:  Jai D Parekh; Susan E Wozniak; Kamran Khan; Sudhir K Dutta
Journal:  BMJ Case Rep       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.